article thumbnail

Buried Under Dirt or Under Debt: Can Patients Survive the Struggle of Getting Care?

HIT Consultant

One double-sided page features information about how to navigate the financial aspects of cancer treatment, including who to contact for help with medical bills. As the founder of a technology company focused on helping people afford their medical bills, I have spoken with many patients, physicians, nurses and financial analysts.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

84% of Americans told the Foundation that they were concerned about how much health care costs will affect them in the future, with 42% of patients saying they couldn’t afford to pay over $500 for an unexpected medical bill. Hospital costs contribute to rising medical costs to 49% of health consumers. Exacerbating U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

At the end of this day, something Muna Bhanji, an advisor to biopharmaceutical developers who spent over 30 years of her career with Merck, noted: no advances toward value-based care will happen without a sense of partnership, requiring aligned incentives across the health/care ecosystem.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

Lawmaker: Revisions coming to Georgia mental health bill. Local hospitals begin enforcing medical worker vaccine mandates. Family shocked after receiving medical bill that cost more than double what they expected. top medical official doesn’t expect a COVID surge after Mardi Gras.

article thumbnail

The Pharma Industry Hits Bottom of Consumers’ Industry Rankings, and Healthcare Is Only Marginally Higher on the List

Health Populi

Gallup notes that Americans are over two times more likely to rank the pharmaceutical industry negatively (58%) as positively (27%). Gallup points out that the pharma industry has generally ranked lower than other sectors since 2001, the beginning of this study. “The pharmaceutical industry’s U.S.